Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue	$ 38,753	$ 41,465	$ 121,197	$ 123,691
Cost of product revenue	37,313	16,521	67,764	46,932
Gross Profit	1,440	24,944	53,433	76,759
Operating Expenses:
Research & development	7,244	7,791	22,806	25,105
Selling, general & administrative	19,112	24,827	60,445	75,512
Long lived asset impairment	3,101	0	3,101	0
Total operating expenses	29,457	32,618	86,352	100,617
Loss from operations	(28,017)	(7,674)	(32,919)	(23,858)
Interest and other income, net	406	635	1,593	1,735
Loss before income taxes	(27,611)	(7,039)	(31,326)	(22,123)
Provision for (benefit from) income taxes	2,307	(463)	3,194	(2,456)
Net loss	$ (29,918)	$ (6,576)	$ (34,520)	$ (19,667)
Net loss per share:
Basic (in dollars per share)	$ (2.03)	$ (0.45)	$ (2.34)	$ (1.34)
Diluted (in dollars per share)	$ (2.03)	$ (0.45)	$ (2.34)	$ (1.34)
Weighted average common shares outstanding:
Basic (in shares)	14,768	14,635	14,769	14,659
Diluted (in shares)	14,768	14,635	14,769	14,659
Net loss	$ (29,918)	$ (6,576)	$ (34,520)	$ (19,667)
Foreign currency translation adjustment	715	(407)	242	(121)
Comprehensive loss	$ (29,203)	$ (6,983)	$ (34,278)	$ (19,788)